On Jan. 19, two regulatory changes went into effect that intend to modernize the Physician Self-Referral Statute & the Anti-Kickback Statute, facilitating the shift to value-based care.
CuraCloud announced today that its computer-aided triage and notification system for the early recognition of ICH has receive clearance from the U.S. FDA.
On March 20, the research results of Keya Medical’s COVID-19 AI Assisted Diagnosis algorithm were published in the peer-reviewed journal Radiology.
A new FDA public workshop focused on questions of safety and effectiveness of emerging AI-enabled technologies, such as autonomous AI, adaptive AI, and AI-guided image acquisition systems.
Keya Medical announced today that it has received a strategic investment from Kunlun Wanwei Group, IDG Capital, Shanghai Guofang Parent Fund, and Yahui Capital.
On January 15, 2020, the National Medical Products Administration in China issued the registration certificate approving DeepVessel FFR for clinical use.
Explore the risks and benefits of AI applications in radiology, according to industry stakeholders and the U.S. FDA.
Keya Medical Attends 10th Summit on Scientific and Technological Innovation in Major Disease Control
The 10th Summit on Scientific and Technological Innovation in Major Disease Control sponsored by the Beijing Municipal Science and Technology Commission, took place on Dec. 21, 2019 at the National Convention Center.
The Future Medical 100 Annual Conference was held Dec. 20, 2019 in Beijing Jiuhua Villa. Keya Medical was among the companies listed on the Top 100 List, and DEEPVESSEL FFR made the list of the Top 5 FFR Products in China.
Keya Medical and Shunde Hospital of Southern Medical University Bring Non-invasive CT-FFR to Patients
Keya Medical’s non-invasive CT-FFR product, DEEPVESSEL FFR, was officially implemented in Shunde Hospital of Southern Medical University.
As a member of NVIDIA’s Inception Program, CuraCloud has had early access to NVIDIA’s AI development tools, including NVIDIA Clara, the NVIDIA EGX Intelligent Edge Computing Platform, and NVIDIA AGX for embedded systems.
Keya Medical’s non-invasive coronary evaluation software, DEEPVESSEL FFR, was successfully installed at China Civil Aviation General Hospital on Dec. 2, 2019.
Understanding the Turnaround Time Effects of an AI-based Prioritization System for Intracranial Hemorrhage
We built a Monte Carlo simulation to understand the turnaround time effects of an AI-based prioritization system for intracranial hemorrhage.